| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5614684 | Journal of Cardiology | 2017 | 4 Pages |
Abstract
The SAFE-A study is the first randomized controlled trial to compare 1-month vs. 6-month P2Y12 inhibitor therapy in combination with aspirin and apixaban, in patients with atrial fibrillation who undergo DES implantation. This study will provide data that may guide the optimal management of triple antithrombotic therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Tomoya MD, Akira MD, FJCC, Akihiko MD, Masahiko PhD, Kazutaka MD, FJCC, SAFE-A Investigators SAFE-A Investigators,